Addentax (ATXG) had the highest return between October 1, 2017 and May 31, 2018 by a US stock, returning 19,730,085.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Addentax (ATXG) | 10/1/2017 - 5/31/2018 | 19,730,085.5% |
Delcath Systems (DCTH) | 10/1/2017 - 5/31/2018 | 3,455,455.56% |
Avalon GloboCare (ALBT) | 10/1/2017 - 5/31/2018 | 1,724,900% |
GT Biopharma (GTBP) | 10/1/2017 - 5/31/2018 | 14,778.06% |
Alarum Technologies (ALAR) | 10/1/2017 - 5/31/2018 | 8,290% |
SurgePays (SURG) | 10/1/2017 - 5/31/2018 | 3,617.95% |
Focus Universal (FCUV) | 10/1/2017 - 5/31/2018 | 1,100% |
Quantum Computing (QUBT) | 10/1/2017 - 5/31/2018 | 1,092.31% |
Ryvyl (RVYL) | 10/1/2017 - 5/31/2018 | 801.07% |
TON Strategy (TONX) | 10/1/2017 - 5/31/2018 | 770.59% |
MDxHealth SA ADR (MDXH) | 10/1/2017 - 5/31/2018 | 760% |
Viewbix Inc Common Stock (VBIX) | 10/1/2017 - 5/31/2018 | 737.7% |
Thryv (THRY) | 10/1/2017 - 5/31/2018 | 670.89% |
Applied Digital (APLD) | 10/1/2017 - 5/31/2018 | 583.33% |
Madrigal Pharmaceuticals (MDGL) | 10/1/2017 - 5/31/2018 | 488.28% |
Turtle Beach (TBCH) | 10/1/2017 - 5/31/2018 | 430.49% |
Viking Therapeutics (VKTX) | 10/1/2017 - 5/31/2018 | 397.01% |
Avalo Therapeutics (AVTX) | 10/1/2017 - 5/31/2018 | 394.05% |
Gyre Therapeutics (GYRE) | 10/1/2017 - 5/31/2018 | 386.78% |
eGain (EGAN) | 10/1/2017 - 5/31/2018 | 326.67% |
argenx NV ADR (ARGX) | 10/1/2017 - 5/31/2018 | 324.63% |
Ridgepost Capital (RPC) | 10/1/2017 - 5/31/2018 | 320.03% |
Paysign (PAYS) | 10/1/2017 - 5/31/2018 | 320% |
Nutriband (NTRB) | 10/1/2017 - 5/31/2018 | 304.87% |
BlueLinx (BXC) | 10/1/2017 - 5/31/2018 | 291.79% |
